Talks at GS

In this episode, Admiral Timothy Keating, the former Commander of the US Pacific Command, and Brigadier General Robert S. Spalding III, the former Senior Director for Strategic Planning at the National Security Council, discuss coronavirus and the geopolitical implications for China. The interview is moderated by Goldman Sachs' Norman Nigh.

This episode was recorded as a call on April 15, 2020.

This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Goldman Sachs’ Sharmin Mossavar-Rahmani discusses the latest developments on COVID-19 therapies and vaccines with a group of leading experts. This podcast was recorded as a phone call on April 14, 2020.

Participants include:

Dr. Richard Hatchett, CEO of Coalition for Epidemic Preparedness Innovations

Esther Krofah, Executive Director of FasterCures

Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson

Click below to view materials referenced during the podcast:

https://www.goldmansachs.com/insights/talks-at-gs/04-15-2020-an-update-on-covid-19-therapies-and-vaccines-f/presentation.pdf

This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Jovita Carranza, the administrator of the U.S. Small Business Administration (SBA), discusses her leadership of the SBA during the coronavirus pandemic, the economic impact of the pandemic on the small business community, and federal relief for that community during the crisis. The interview is moderated by Goldman Sachs' Chairman and CEO David Solomon.

This episode was recorded as a call on April 9, 2020.

This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, journalist Jonathan Karl discusses covering the Trump administration during the coronavirus crisis as well as his insights from covering President Trump for decades, as described in his new book, Front Row at the Trump Show. The interview is moderated by Goldman Sachs' Jake Siewert.

The interview was recorded on April 1, 2020.

This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Talks at GS, Goldman Sachs’ Sharmin Mossavar-Rahmani discusses the economic implications of the recently passed Coronavirus Aid, Relief, and Economic Security Act with a group of leading economic experts. This conversation was recorded as a phone call on March 31, 2020.

Click below to view materials referenced during the podcast:

https://www.goldmansachs.com/insights/talks-at-gs/04-01-20-cares-act-impact-on-us-economic-outlook-f/report.pdf

Participants include:

Alec Phillips, Chief US Political Economist, Goldman Sachs Research

Jan Hatzius, Chief Economist, Goldman Sachs Research

William G. Gale, Arjay and Frances Miller Chair in Federal Economic Policy and senior fellow, Brookings Institution

This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Talks at GS, US Senators Marco Rubio and Ben Cardin discuss the federal policy response to the coronavirus pandemic and how the recently passed Coronavirus Aid, Relief, and Economic Security Act impacts small businesses. The conversation is moderated by Goldman Sachs Chairman and CEO David Solomon and recorded as a phone call on March 30, 2020.

This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Talks at GS, Goldman Sachs’ Sharmin Mossavar-Rahmani discusses the economic and public health implications of coronavirus for Europe with a number of leading health and economic experts. This conversation was recorded as a phone call on March 26, 2020.

Click below to view materials referenced during the podcast:

https://www.goldmansachs.com/insights/talks-at-gs/03-26-20-update-coronavirus-europe-f/report.pdf

Participants include:

Dr. David Heymann, MD, Professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine

Sven Jari Stehn, Managing Director, Goldman Sachs Research

Silvia Ardagna, Managing Director, Goldman Sachs Investment Strategy Group

Peter Oppenheimer, Managing Director, Goldman Sachs Research

This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Goldman Sachs’ Sharmin Mossavar-Rahmani discusses coronavirus testing, hospital readiness and the search for a therapy and vaccine with a number of leading health experts and business leaders.

Click below to view materials referenced during the podcast:

https://www.goldmansachs.com/insights/talks-at-gs/sharmin-mossavar-rahmani-f/deck.pdf

Participants include:

Dr. Thomas Schinecker, CEO of Roche Diagnostics

Steve Rusckowski, CEO of Quest Diagnostics

Dr. Leonard Schleifer, MD, CEO of Regeneron

Stéphane Bancel, CEO of Moderna

Pablo Tebas, MD, University of Pennsylvania and National Institute of Health Supported Investigator

Peter Slavin, MD, President, Massachusetts General Hospital

Dr. Barry Bloom, Harvard T.H. Chan School of Public Health

This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Dr. Michael Mina of the Harvard T.H. Chan School of Public Health discusses the evolving understanding of COVID-19 biology and epidemiology and approaches to “flatten the curve” in the context of diagnostics, potential therapeutics and vaccines. This conversation was recorded as a phone call between Dr. Mina and Salveen Richter and Terence Flynn of Goldman Sachs Research on March 17, 2020.

This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Historian Rick Atkinson discusses his new historical trilogy on the American Revolution, the enduring lessons from the early battles of that war and the key figures at the center of the fight – from George Washington to King George III. The interview is moderated by Goldman Sachs' Lloyd Blankfein.

Date: November 5, 2019

This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

Learn more about your ad choices. Visit megaphone.fm/adchoices